Related Experiment Video

Updated: Aug 15, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Mutations of C-RAF are rare in human cancer because C-RAF has a low basal kinase activity compared with B-RAF

Victoria Emuss1, Mathew Garnett, Clive Mason

  • 1The Institute of Cancer Research, Signal Transduction Team, Cancer Research UK Centre of Cell and Molecular Biology, London, United Kingdom.

Cancer Research
|November 4, 2005
PubMed

Insights

Mutations in B-RAF kinase are common in cancers, unlike its C-RAF counterpart. This study reveals C-RAF mutations are rare due to fundamental differences in RAF isoform regulation, explaining B-RAF

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • The B-RAF protein kinase is frequently mutated in human cancers, driving tumor growth.
  • Understanding the mutational landscape of related kinases like C-RAF is crucial for cancer research.

Purpose of the Study:

  • To investigate the frequency and functional impact of C-RAF mutations in cancer.
  • To elucidate the molecular mechanisms underlying the differential mutation rates between B-RAF and C-RAF in cancer.

Main Methods:

  • Screening of 545 cancer cell lines for C-RAF mutations.
  • Biochemical assays to assess kinase activity, RAS activation, and transforming potential of C-RAF variants.
  • Introduction of the common B-RAF V600E mutation into C-RAF to evaluate its effect.

Main Results:

  • C-RAF mutations were detected in only 0.7% of cancer cell lines, significantly rarer than B-RAF mutations.
  • Identified C-RAF variants with altered RAS activation or basal activity, but none exhibited oncogenic transformation.
  • Introducing the B-RAF V600E mutation into C-RAF resulted in only a weak effect on kinase activity, failing to confer oncogenic potential.

Conclusions:

  • C-RAF mutations are rare in cancer, contrasting with frequent B-RAF mutations.
  • Fundamental differences in RAF isoform regulation, specifically the lack of constitutive charge in C-RAF's N-region, explain this disparity.
  • These findings highlight distinct roles of RAF isoforms in cancer pathogenesis and provide insights into targeted therapy development.

More Related Videos

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells06:44

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells

Published on: March 1, 2024

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...